美国毒品局在最高法院的裁决和公众的强烈反对中捍卫大麻的第I名单地位. DEA defends marijuana's Schedule I status amid Supreme Court ruling and public backlash.

缉毒局面临压力,要根据最高法院的裁决和广泛的公众反弹,为大麻分类为附表一所列药物进行辩护。 The DEA is facing pressure to defend its marijuana classification as a Schedule I drug following a Supreme Court ruling and widespread public backlash. 这一决定导致了法律上的质疑和混乱,许多州正在走向合法化。 The decision has led to legal challenges and confusion, with many states moving towards legalization. 该机构正在接受审查,以证明它在日益支持大麻改革的情况下所持立场是合理的。 The agency is under scrutiny to justify its stance amid growing support for marijuana reform.